THE preceding paper (Wrathmell, 1976) described the growth pattern of a transplantable acute myeloid leukaemia of rats, referred to as SAL. Attempts to induce rejection or even to delay the rate of growth of this transplantable leukaemia by prior hyperimmunization of syngeneic recipients with irradiated leukaemia cells or by stimulation with BCG or Corynebacteritum parvum were unsuccessful (Wrathmell and Alexander, 1973) and the only indication for the presence of a tumour specific transplantation-type antigen (TSTA) on SAL cells came from experiments in which specifically immune thoracic duct cells were effective as immunotherapy (Wrathmell and Alexander, 1973) and from an investigation (Wrathmell and Alexander, 1976) in which hyperimmunization with mitomycin-C treated SAL cells slowed the growth of subsequently inoculated SAL cells.
We now report that marked resistance to SAL can be induced by immunizing syngeneic August rats with a variety of cells from rats of the Hooded strain.* This observation arose from an experiment in which August rats were immunized with leukaemic cells (referred to as " HRL ") which had arisen spontaneously in a Hooded rat. This initial experiment was designed to test whether SAL and HRL shared a TSTA and whether a host response might be facilitated by presenting a TSTA on an allogeneic background. HRL cells when inoculated into August rats (in which they do not grow) gave increased protection against a challenge of SAL. A similar effect could be achieved with normal cells from Hooded rats.
Other investigators (Chang et al., 1972 Katz et al., 1972 Kobayashi et al., 1974; Invernizzi and Parmiani, 1975) have rendered rodents more resistant to syngeneic tumours by immunizing with allogeneic normal cells. In different situations, this effect had been attributed either to the cross reaction of the TSTA of the tumour cell with an alloantigen of the allogeneic cells (Chang et al., 1972; Invernizzi and Parmiani, 1975) or to non-specific stimulation of the immune responsiveness of the host Kobayashi et al., 1974) . In an experiment using guinea-pigs, protection by allogeneic lymphoid cells against a syngeneic leukaemia was attributed Ellman et al., 1972) to the establishment of a graft-versus-host reaction which potentiates immune reactivity (a phenomenon referred to as "the allogeneic effect"), while in rats protection against a sarcoma was attributed to nonspecific stimulation of the reticuloendothelial system by repeatedly administered allogeneic cells (Kobayashi et al., 1974) . The TL antigens (Boyse, Old and Luell, 1963; Boyse, Old and Stockert, 1965) , the MM antigen (Chang et al., 1972) and Glx antigen (Stockert, Old and Boyse, 1971) (Wrathmell, 1976) . HSN is a benzpyreneinduced fibrosarcoma syngeneic in female Hooded rats. Transplantation of the leukaemias was via buffy coat cells from the blood of leukaemia rats injected intravenously into recipient rats. HSN fibrosarcoma was transplanted intramuscularly using 0-1 ml of tumour mush produced by passage through a sieve.
Celt suspensions.-Spleen and thymus cell suspensions were prepared by gently squeezing the tissue with forceps into TC 199. HRL and SAL cells for immunization purposes were obtained from the spleens of leukaemic animals. Liver cell suspensions were prepared from exsanguinated rats.
Embryonic cetls.-10-day foetuses were broken up by passing through a sieve. Xirradiated material was used for the first immunization; non-irradiated material for the second.
Cultured fibrobtasts.-Cultured fibroblasts were obtained by gentle trypsinization from a line which had been subcultured a number of times and which did not cause tumours on inoculation into syngeneic rats.
Immunization.-Rats were immunized twice at 10-day intervals at 4 sites subcutaneously and i.p. Equal amounts of antigen were injected per site, each animal receiving in total 5 x 107 cells in suspension or 0-5ml of tumour mush. Rats were challenged 10 days after the second immunization. X-irradiated cells used for immunization were given 6000 rad x-rays from a Marconi x-ray machine 220 kV (no filter) at a dose rate of 800 rad/min. Mitomycin treated cells were incubated at a concentration of 107 cells/ml with 10 ,ug of mitomycin-C at 3700 for 30 min.
Antisera.-Wistar rats immunized with Hooded spleen cells as outlined above were bled 10 days after the second immunization. The Wistar anti-SAL serum was raised by coating the SAL cells with Wistar antiAugust spleen sera before injection into Wistar rats. Syngeneic August anti-SAL sera were raised by inoculating mitomycin-Ctreated SAL cells 3 times at 10-day intervals.
Absorption of antisera.-All in vitro absorptions were carried out at 40C for 1 h, following which the sera were passed through 0-45 ,m millipore filters and centrifuged for 15 min at 10,000 g. Two ml of the Wistar anti-SAL serum was injected intraperitoneally in a normal adult male August rat and bled 4 h later. Two ml of this serum was then absorbed with normal August cells and with Wistar macrophages, bone marrow and spleen as described.
The August anti-mitomycin-C treated SAL cell serum was absorbed with Wistar tissues as described above.
Measurement of membrane immunofluorescence.-All sera were tested against viable target cells by the indirect sandwich technique at 4°C. The test sera were added for 30 min. This was followed by 3 washes with cold medium 199, after which the goat anti-rat Ig fluorescent conjugate (supplied by Nordic) was used at a dilution of 1/30 at which concentration it did not cause detectable fluorescence of the target cells. The labelled cells were examined by epi-illumination from a caesium-iodide light source in a Zeiss photomicroscope III fitted with planapochromatic objectives. The fine speckled membrane fluorescence was scored at a magnification of 620. The endpoint was takenasthelowest dilution of serum giving positive membrane fluorescence.
Detection of antibody by reducing migration of SAL cells.-The procedure used involved the measurement ofmigration from a capillary tube as described by Currie and Sime (1973) . The cells were preincubated with the sera at different dilutions for 45 min at 4°C, then washed and migrated into 10% heat inactivated foetal calf serum in RPM1. Quadruplicates were carried out for each serum dilution and the dilution that gave 30% inhibition was derived from the titration curve and taken as the end-point.
RESULTS
Resistance to SAL leukaemia induced by cells from Hooded rats Table I shows that immunization with different cell types of Hooded phenotype, malignant as well as normal, protects August rats against a subsequent i.p. challenge with 100 SAL cells. In untreated August rats this cell dose is invariably fatal in less than 20 days and protection is manifested both by prolonga- The protection observed following immunization with non-lymphoid Hooded cells and by irradiated Hooded spleen cells cannot be attributed to stimulation by an " allogeneic " effect as described by Ellman et al. (1972) since such cells would be unable to induce a graft-versus-host reaction. The possibility that a graftversus-host reaction may be responsible for the resistance induced by viable Hooded lymphoid cells was excluded by immunization of August rats with spleen cells from F1 hybrids (August x Hooded). Such spleen cells cannot induce a graftversus-host reaction in an August rat but carry Hooded antigens and will therefore induce immunity to such antigens. The finding (see Table I (Table IV) .
Two types of absorbed allosera and a syngeneic hyperimmune serum were tested by immunfluorescence (see Table II We are clearly not dealing with a genetic defect (e.g. an Ir gene deficit) which prevents the August rat from responding to Ho-SAL, as is the case for some mouse strains which fail to react to the strong leukaemia-related antigen, X-1 (Sato et al., 1973) . Two mechanisms which are not mutually exclusive can be envisaged: (1) response to the Ho-SAL antigen requires the presence of another antigen, as was found to be the case for the TSTA of E.L.4. leukaemia cells (Gorer and Amos, 1946 ) and for certain non-H-2 transplantation antigens (Sanderson, 1964) ; (2) x-irradiation, and to a lesser extent treatment with mitomycin-C, may impair the immunogenicity of SAL with respect to the Ho-SAL antigen, as has been suggested for the TSTA of certain rat sarcomata (Proctor, Rudenstam and Alexander, 1974; Wrathmell and Alexander, 1976 ).
Ho-SAL has a formal similarity to TL, Glx and MM antigens in that they are tumour specific in some strains but are normal alloantigens in others. Ho-SAL, however, differs from these mouse antigens in, (1) 
